Should we be testing for antiphospholipid antibodies in unexplained pulmonary thromboembolism and atherosclerosis at autopsy?
Christopher Bierton, Neil E I Langlois
Author Information
- Christopher Bierton: School of Medicine, University of Adelaide, Frome Road, Adelaide, SA, 5005, Australia.
No abstract text available.
- Immunobiology. 2003;207(1):5-11
[PMID: 12638896]
- J Rheumatol. 1995 Jan;22(1):62-6
[PMID: 7699684]
- Am J Med. 2000 Dec 1;109(8):635-41
[PMID: 11099683]
- Lupus. 2013 Jan;22(1):92-4
[PMID: 23154322]
- Ann Intern Med. 1992 Dec 15;117(12):997-1002
[PMID: 1443986]
- J Intern Med. 1995 Nov;238(5):437-43
[PMID: 7595183]
- J Thromb Haemost. 2006 Feb;4(2):295-306
[PMID: 16420554]
- Am J Med. 1996 May;100(5):530-6
[PMID: 8644765]
- Circulation. 2005 Jul 19;112(3):e39-44
[PMID: 16027261]
Antibodies, Antiphospholipid
Antiphospholipid Syndrome
Atherosclerosis
Autopsy
Biomarkers
Cause of Death
Humans
Pulmonary Embolism
Risk Factors
Antibodies, Antiphospholipid
Biomarkers